LU76145A1 - - Google Patents
Info
- Publication number
- LU76145A1 LU76145A1 LU76145A LU76145A LU76145A1 LU 76145 A1 LU76145 A1 LU 76145A1 LU 76145 A LU76145 A LU 76145A LU 76145 A LU76145 A LU 76145A LU 76145 A1 LU76145 A1 LU 76145A1
- Authority
- LU
- Luxembourg
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/85—Reproductive organs or embryos
- Y10S530/851—Placenta; amniotic fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Immunology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2550011A DE2550011C2 (de) | 1975-11-07 | 1975-11-07 | Verfahren zur Herstellung eines antihämophilen Mittels |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU76145A1 true LU76145A1 (no) | 1977-06-03 |
Family
ID=5961172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU76145A LU76145A1 (no) | 1975-11-07 | 1976-11-05 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4067964A (no) |
| JP (1) | JPS6029362B2 (no) |
| AT (1) | AT358737B (no) |
| AU (1) | AU500621B2 (no) |
| BE (1) | BE848111A (no) |
| CA (1) | CA1077393A (no) |
| CH (1) | CH630805A5 (no) |
| DE (1) | DE2550011C2 (no) |
| DK (1) | DK502176A (no) |
| ES (1) | ES452923A1 (no) |
| FI (1) | FI763165A7 (no) |
| FR (1) | FR2330408A1 (no) |
| GB (1) | GB1563009A (no) |
| IL (1) | IL50847A (no) |
| IT (1) | IT1063617B (no) |
| LU (1) | LU76145A1 (no) |
| NL (1) | NL7612139A (no) |
| NO (1) | NO763776L (no) |
| SE (1) | SE7612396L (no) |
| ZA (1) | ZA766647B (no) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3165600D1 (en) * | 1980-01-28 | 1984-09-27 | Baxter Travenol Lab | Prothrombin-containing therapeutic compositions and methods of producing enzymatically active blood clotting factors from prothrombin-containing blood fractions |
| US4459288A (en) * | 1981-05-11 | 1984-07-10 | Baxter Travenol Laboratories, Inc. | Therapeutic blood clotting factor compositions and their use |
| DE3625090A1 (de) * | 1986-07-24 | 1988-01-28 | Behringwerke Ag | Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung |
| CA1339946C (en) * | 1987-03-31 | 1998-07-07 | Michael J. Griffith | Ultrapurification process for polypeptides |
| JP2931319B2 (ja) * | 1989-03-29 | 1999-08-09 | 吉富製薬株式会社 | 血液凝固第▲ｖｉｉｉ▼因子の製造法 |
| JP3180824B2 (ja) * | 1991-08-30 | 2001-06-25 | シスメックス株式会社 | 血液凝固試薬 |
| CA2437015A1 (en) * | 2001-02-05 | 2002-08-15 | Novo Nordisk Health Care Ag | Combined use of factor vii polypeptides and factor ix polypeptides |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3862002A (en) * | 1962-05-08 | 1975-01-21 | Sanfar Lab Inc | Production of physiologically active placental substances |
| BE713764A (no) * | 1967-05-01 | 1968-09-16 | Baxter Travenol Lab | |
| BE787961A (fr) * | 1971-08-24 | 1973-02-26 | Behringwerke Ag | Procede d'isolement d'une matiere thromboplastique et medicament contenant ladite matiere |
| DE2262520C3 (de) * | 1972-12-20 | 1987-02-12 | Miles Laboratories, Inc., Elkhart, Ind. | Verfahren zur Herstellung eines lyophilisierten, lagerfähigen Konzentrats aus menschlichem Plasma |
-
1975
- 1975-11-07 DE DE2550011A patent/DE2550011C2/de not_active Expired
-
1976
- 1976-11-02 NL NL7612139A patent/NL7612139A/xx not_active Application Discontinuation
- 1976-11-02 ES ES452923A patent/ES452923A1/es not_active Expired
- 1976-11-04 AT AT819476A patent/AT358737B/de not_active IP Right Cessation
- 1976-11-04 IL IL50847A patent/IL50847A/xx unknown
- 1976-11-04 CH CH1392076A patent/CH630805A5/de not_active IP Right Cessation
- 1976-11-04 FI FI763165A patent/FI763165A7/fi not_active Application Discontinuation
- 1976-11-05 LU LU76145A patent/LU76145A1/xx unknown
- 1976-11-05 NO NO763776A patent/NO763776L/no unknown
- 1976-11-05 US US05/739,278 patent/US4067964A/en not_active Expired - Lifetime
- 1976-11-05 AU AU19341/76A patent/AU500621B2/en not_active Expired
- 1976-11-05 ZA ZA766647A patent/ZA766647B/xx unknown
- 1976-11-05 CA CA265,060A patent/CA1077393A/en not_active Expired
- 1976-11-05 SE SE7612396A patent/SE7612396L/xx unknown
- 1976-11-05 DK DK502176A patent/DK502176A/da unknown
- 1976-11-05 IT IT29084/76A patent/IT1063617B/it active
- 1976-11-06 JP JP51132782A patent/JPS6029362B2/ja not_active Expired
- 1976-11-08 GB GB46384/76A patent/GB1563009A/en not_active Expired
- 1976-11-08 FR FR7633603A patent/FR2330408A1/fr active Granted
- 1976-11-08 BE BE172170A patent/BE848111A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NL7612139A (nl) | 1977-05-10 |
| GB1563009A (en) | 1980-03-19 |
| FR2330408B1 (no) | 1980-03-14 |
| SE7612396L (sv) | 1977-05-08 |
| CH630805A5 (de) | 1982-07-15 |
| AU500621B2 (en) | 1979-05-24 |
| CA1077393A (en) | 1980-05-13 |
| AT358737B (de) | 1980-09-25 |
| AU1934176A (en) | 1978-05-11 |
| ES452923A1 (es) | 1977-11-16 |
| DK502176A (da) | 1977-05-08 |
| FR2330408A1 (fr) | 1977-06-03 |
| DE2550011C2 (de) | 1982-11-25 |
| NO763776L (no) | 1977-05-10 |
| DE2550011A1 (de) | 1977-05-12 |
| ZA766647B (en) | 1977-10-26 |
| IT1063617B (it) | 1985-02-11 |
| FI763165A7 (no) | 1977-05-08 |
| JPS5257310A (en) | 1977-05-11 |
| ATA819476A (de) | 1980-02-15 |
| BE848111A (fr) | 1977-05-09 |
| JPS6029362B2 (ja) | 1985-07-10 |
| US4067964A (en) | 1978-01-10 |
| IL50847A (en) | 1980-01-31 |
| IL50847A0 (en) | 1977-01-31 |